• Partner With Us
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Abundance & Growth
      • Effective Giving & Careers
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Global Public Health Policy
      • Scientific Research
    • Global Catastrophic Risks
      • Biosecurity & Pandemic Preparedness
      • Forecasting
      • Global Catastrophic Risks Capacity Building
      • Potential Risks from Advanced AI
    • Other Areas
      • History of Philanthropy
  • Grants
  • Research & Updates
    • Blog Posts
    • In the News
    • Research Reports
    • Notable Lessons
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Careers
    • Team
    • Operating Values
    • Stay Updated
    • Contact Us
  • Partner With Us
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Abundance & Growth
      • Effective Giving & Careers
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Global Public Health Policy
      • Scientific Research
    • Global Catastrophic Risks
      • Biosecurity & Pandemic Preparedness
      • Forecasting
      • Global Catastrophic Risks Capacity Building
      • Potential Risks from Advanced AI
    • Other Areas
      • History of Philanthropy
  • Grants
  • Research & Updates
    • Blog Posts
    • In the News
    • Research Reports
    • Notable Lessons
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Careers
    • Team
    • Operating Values
    • Stay Updated
    • Contact Us

RAND Corporation — Research for Vermont

Visit Grantee Site
  • Category: Global Health & Wellbeing
  • Organization Name: RAND Corporation
  • Amount: $103,000

  • Award Date: August 2014

Table of Contents

    Beau Kilmer, co-director of the RAND Drug Policy Research Center and leader of the Vermont study. (Photo courtesy of the RAND Corporation)

    Staff of the RAND Corporation reviewed this page prior to publication.

    Note: This page was created using content published by Good Ventures and GiveWell, the organizations that created the Open Philanthropy Project, before this website was launched. Uses of “we” and “our” on this page may therefore refer to Good Ventures or GiveWell, but they still represent the work of the Open Philanthropy Project.

    Vermont is considering becoming the first state to legalize the production and possession of recreational marijuana through the state Legislature rather than through a ballot measure, which may give it the potential to weigh different legalization options in a more nuanced way than other states have done.

    In May 2014, the Governor of Vermont signed a bill into law requiring his Secretary of Administration to produce a report about the consequences of legalizing marijuana (with no explicit funding source for the study). The RAND Corporation requested funding from the Open Philanthropy Project to be able to conduct a thorough report, written for policymakers, that would be useful both for Vermont and for other states and localities exploring marijuana legalization in the future. While some report would be produced in the absence of the Open Philanthropy Partnership’s funding, we believe that providing funding will likely improve the quality of the report as a guide for policymakers.

    Given our previous interest in the issue and the potential for influencing the policy in Vermont and beyond, Good Ventures decided to award $103,000 to the RAND Corporation for completion of the report.

    Update: the report is now available here (PDF archive).

    Rationale for the Grant

    Good Ventures has identified drug policy reform as a priority area for further investigation through possible learning grants. Through the grants we have given so far, and especially through the work of Mark Kleiman, we have come to believe that it is important to think about how drug legalization or decriminalization is done, and not just whether it is done.

    Background on RAND

    The RAND Corporation is a “nonprofit, nonpartisan research organization that [aims to] help … improve policy and decisionmaking through research and analysis.”1 Our general impression is that RAND is a well-respected, non-partisan research institution.2 According to its website, the RAND Drug Policy Research Center “has conducted research [since 1989] to help community leaders and public officials develop more effective ways of dealing with drug problems…. The Center’s goal is to provide a firm, empirical foundation on which sound policies can be built.”3 Our impression is that Beau Kilmer, the Center’s co-director and the leader on the report, is a widely-respected researcher;4 he is also a frequent co-author with one of our other grantees, Professor Mark Kleiman at UCLA.

    Proposed activities

    Vermont is considering becoming the first state to legalize recreational marijuana use through the state Legislature rather than through a ballot measure,5 which may give it the potential to weigh different legalization options in a more nuanced way than other states have.

    In May 2014, the Governor of Vermont signed a bill into law requiring the Secretary of Administration to produce a report about the consequences of legalizing marijuana.6 This puts Vermont in the position of being able to examine other jurisdictions’ experiences with marijuana regulation to inform future discussions about its own marijuana policy.

    RAND aims to write a report, targeted at policymakers, that will be useful both for Vermont and for other states and localities looking for a summary of the costs and benefits of different ways to regulate marijuana. While the law sets out some specific topics that the report must cover (e.g., “savings or costs to the State that would result from regulating marijuana”),7 our understanding is that the majority of the report would likely be a literature review, written for policy makers, of the experiences of other locations that have regulated marijuana (Colorado, Washington, Uruguay). People have written about the experiences of those locations before, but, to our knowledge, it is not summarized in one place or written in a format accessible for policymakers.8

    After the report is finished, it will be public on RAND’s website and available for other jurisdictions looking for a useful summary of the tradeoffs associated with different approaches to regulating marijuana. In keeping with the statutory requirement, the report will be completed by January 15, 2015.9

    Room for more funding and fungibility

    Vermont’s bill did not appropriate any funds for the purpose of carrying out that study, but the Secretary of Administration was able to find $20,000 to help fund the study.10 Beau Kilmer believes, however, that a useful study would cost at least $123,000, with the bulk of funds devoted to paying contributors for their time.11 Kilmer reports that he sought funding from other foundations but was unable to secure any additional funding.

    Given that a report is required by law, one would certainly be produced in the absence of funding from Good Ventures; however, the report would be produced by less expensive (and presumably less experienced) researchers rather than RAND.

    Risks and Reservations

    This is a relatively low-risk grant, especially since the grant size is relatively small. Potential risks include:

    • Concerns about cost-effectiveness:
      • Vermont is not guaranteed to legalize marijuana or even propose alternative marijuana legislation; if it does not, the report could be significantly less useful.
      • A report is required by law, so it is hard to know whether the report we are funding will be that much more useful than the report that could be produced by a less expensive researcher.
      • RAND’s rates strike us as fairly high (although it is also true that the team of researchers working on the report seems to be of a very high caliber).
    • It may not be ideal to heavily concentrate our initial criminal justice grantmaking within a small, close-knit researcher community.

    Conclusion

    We believe that this grant is worth making. It seems reasonably likely that Vermont will legalize or regulate marijuana in some way, and so a high-quality report will both help inform Vermont policymakers and increase the likelihood that reform is done in a thoughtful way. Even if Vermont ultimately decides not to legalize marijuana, a report like this can be helpful for policymakers in other jurisdictions considering marijuana legalization.

    Learning and follow-up

    Typically, this section of our grant pages are focused on our future plans for learning and followup. In this case, significant delays in the process of preparing this writeup have meant that at the time of writing, the commissioned report has already been released (PDF archive).

    Notes from our conversation with Beau Kilmer after the report’s release are available here. We conducted a limited review of media stories about the report’s launch, and were generally pleased with the tenor and content.12

    We have not yet attempted to gauge the impact of the report on policy in Vermont or elsewhere, and may or may not do so in the future, depending on whether this remains an area of interest for future engagement.

    Our Process

    In June 2014, Mark Kleiman (a grantee) alerted the Open Philanthropy Partnership to the existence of a time-sensitive research opportunity in Vermont, and put us in touch with Beau Kilmer. That contact led to a series of conversations, culminating in the awarding of this grant in July.

    We shared a draft version of this page with RAND staff prior to publication.

    Sources

    DOCUMENT SOURCE
    GiveWell’s non-verbatim summary of a conversation with Mark Kleiman, July 2, 2013 Source
    Governing 2015 Source (archive)
    RAND Drug Policy Research Center Source (archive)
    RAND grant proposal Source
    RAND homepage Source (archive)
    The Washington Post 2015 Source
    USA Today 2015 Source
    Vermont S. 247 Source (archive)
    Vox 2015 Source (archive)
    Expand Footnotes Collapse Footnotes

    1.“Michael D. Rich is president and chief executive officer of the RAND Corporation, a nonprofit, nonpartisan research organization that helps improve policy and decisionmaking through research and analysis.” RAND homepage

    2.This general impression has been reinforced by background conversations with UCLA Professor Mark Kleiman and Graham Boyd, who previously worked as an advisor on marijuana policy issues to the late philanthropist Peter Lewis.

    3.RAND Drug Policy Research Center

    4.We have heard this sentiment in background conversations with UCLA Professor Mark Kleiman and Graham Boyd, who previously worked as an advisor on marijuana policy issues to the late philanthropist Peter Lewis.

    5.“Vermont lawmakers are considering whether to become the first state Legislature to legalize marijuana. Four states and the District of Columbia have legalized recreational cannabis, but in each of those cases, it was voters at the ballot box, not lawmakers, who changed the law. Vermont could become the first state in history where elected officials directly legalize pot, and Gov. Peter Shumlin said he “continues to support” efforts to legalize marijuana.” USA Today 2015

    6.“Sec. 8a. TAXATION AND REGULATION OF MARIJUANA; REPORT
    On or before January 15, 2015, the Secretary of Administration shall report
    to the General Assembly regarding the taxation and regulation of marijuana in
    Vermont. The report shall analyze:
    (1) the possible taxing systems for the sale of marijuana in Vermont,
    including sales and use taxes and excise taxes, and the potential revenue each
    may raise;
    (2) any savings or costs to the State that would result from regulating
    marijuana; and
    (3) the experiences of other states with regulating and taxing marijuana.” Pg. 13, Vermont S. 247

    7.“Sec. 8a. TAXATION AND REGULATION OF MARIJUANA; REPORT
    On or before January 15, 2015, the Secretary of Administration shall report
    to the General Assembly regarding the taxation and regulation of marijuana in
    Vermont. The report shall analyze:
    (1) the possible taxing systems for the sale of marijuana in Vermont,
    including sales and use taxes and excise taxes, and the potential revenue each
    may raise;
    (2) any savings or costs to the State that would result from regulating
    marijuana; and
    (3) the experiences of other states with regulating and taxing marijuana.” Pg. 13, Vermont S. 247

    8.Beau Kilmer and Mark Kleiman have attested to this in background conversations.

    9.“Sec. 8a. TAXATION AND REGULATION OF MARIJUANA; REPORT
    On or before January 15, 2015, the Secretary of Administration shall report
    to the General Assembly regarding the taxation and regulation of marijuana in
    Vermont.” Pg. 13, Vermont S. 247

    10.“The new law did not dedicate funds for this study, but the Secretary was able to secure $20,000 to offset some of the study costs.” Pg. 1, RAND grant proposal

    11.“BUDGET: $123,000.” Pg. 2, RAND grant proposal

    12.See, e.g.:

    Governing 2015

    The Washington Post 2015

    Vox 2015

    Related Items

    • Global Health & Wellbeing

      RAND Corporation — Study Planning

      Open Philanthropy recommended a grant of $25,000 to the RAND Corporation to support planning for a large study on doctors in Nigeria. This falls within our work on...

      Read more
    • Global Health & Wellbeing

      National Academy of Sciences — Future of Biomedical Databases Study

      Open Philanthropy recommended a grant of $75,000 to the National Academy of Sciences to support a study on the future of biological databases. This work will engage dozens...

      Read more
    • Global Health & Wellbeing

      University of Warwick — Evidence-Based Policymaking

      Open Philanthropy recommended a grant of £17,000 (approximately $21,490 at the time of conversion) to the University of Warwick to support a joint workshop between academics and...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • We’re Hiring!
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    info@openphilanthropy.org
    Media Inquiries
    media@openphilanthropy.org
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2025 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT